{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:24:12Z","timestamp":1792527852128,"version":"4.5.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"crossref","award":["2008085QH408"],"award-info":[{"award-number":["2008085QH408"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81874063"],"award-info":[{"award-number":["81874063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the malignant progression of tumors, there is deposition and cross-linking of collagen, as well as an increase in hyaluronic acid content, which can lead to an increase in extracellular matrix stiffness. Recent research evidence have shown that the extracellular matrix plays an important role in angiogenesis, cell proliferation, migration, immunosuppression, apoptosis, metabolism, and resistance to chemotherapeutic by the alterations toward both secretion and degradation. The clinical importance of tumor-associated macrophage is increasingly recognized, and macrophage polarization plays a central role in a series of tumor immune processes through internal signal cascade, thus regulating tumor progression. Immunotherapy has gradually become a reliable potential treatment strategy for conventional chemotherapy resistance and advanced cancer patients, but the presence of immune exclusion has become a major obstacle to treatment effectiveness, and the reasons for their resistance to these approaches remain uncertain. Currently, there is a lack of exact mechanism on the regulation of extracellular matrix stiffness and tumor-associated macrophage polarization on immune exclusion. An in-depth understanding of the relationship between extracellular matrix stiffness, tumor-associated macrophage polarization, and immune exclusion will help reveal new therapeutic targets and guide the development of clinical treatment methods for advanced cancer patients. This review summarized the different pathways and potential molecular mechanisms of extracellular matrix stiffness and tumor-associated macrophage polarization involved in immune exclusion and provided available strategies to address immune exclusion.<\/jats:p>","DOI":"10.1007\/s00262-024-03675-9","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T02:01:46Z","timestamp":1714615306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion"],"prefix":"10.1007","volume":"73","author":[{"given":"Ke-Xun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"issue":"11","key":"3675_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"D Quail","year":"2013","unstructured":"Quail D, Joyce J (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423\u20131437","journal-title":"Nat Med"},{"issue":"1","key":"3675_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20(1):131","journal-title":"Mol Cancer"},{"key":"3675_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"A Theocharis","year":"2016","unstructured":"Theocharis A, Skandalis S, Gialeli C, Karamanos N (2016) Extracellular matrix structure. Adv Drug Deliv Rev 97:4\u201327","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"3675_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrm3902","volume":"15","author":"J Mouw","year":"2014","unstructured":"Mouw J, Ou G, Weaver V (2014) Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol 15(12):771\u2013785","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"3675_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a005058","volume":"3","author":"P Lu","year":"2011","unstructured":"Lu P, Takai K, Weaver V, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3(12):a005058","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"3675_CR6","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/ijc.23930","volume":"123","author":"S Goldoni","year":"2008","unstructured":"Goldoni S, Iozzo R (2008) Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer 123(11):2473\u20132479","journal-title":"Int J Cancer"},{"key":"3675_CR7","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1242\/jcs.023820","volume":"123","author":"C Frantz","year":"2010","unstructured":"Frantz C, Stewart K, Weaver V (2010) The extracellular matrix at a glance. J Cell Sci 123:4195\u20134200","journal-title":"J Cell Sci"},{"issue":"4","key":"3675_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver V, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196(4):395\u2013406","journal-title":"J Cell Biol"},{"issue":"7","key":"3675_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41563-020-0615-x","volume":"19","author":"T Panciera","year":"2020","unstructured":"Panciera T, Citron A, Di Biagio D, Battilana G, Gandin A, Giulitti S, Forcato M, Bicciato S, Panzetta V, Fusco S et al (2020) Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties. Nat Mater 19(7):797\u2013806","journal-title":"Nat Mater"},{"issue":"5","key":"3675_CR10","first-page":"1009","volume":"69","author":"F Shapiro","year":"1982","unstructured":"Shapiro F, Eyre D (1982) Collagen polymorphism in extracellular matrix of human osteosarcoma. J Natl Cancer Inst 69(5):1009\u20131016","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3675_CR11","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41467-023-38093-5","volume":"14","author":"E Puttock","year":"2023","unstructured":"Puttock E, Tyler E, Manni M, Maniati E, Butterworth C, Burger Ramos M, Peerani E, Hirani P, Gauthier V, Liu Y et al (2023) Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis. Nat Commun 14(1):2514","journal-title":"Nat Commun"},{"key":"3675_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121378","volume":"282","author":"C Robertson","year":"2022","unstructured":"Robertson C, Sebastian A, Hinckley A, Rios-Arce N, Hynes W, Edwards S, He W, Hum N, Wheeler E, Loots G et al (2022) Extracellular matrix modulates T cell clearance of malignant cells in vitro. Biomaterials 282:121378","journal-title":"Biomaterials"},{"issue":"7693","key":"3675_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley S, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel E, Koeppen H, Astarita J, Cubas R et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548","journal-title":"Nature"},{"key":"3675_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev-cellbio-100109-104020","volume":"26","author":"P Singh","year":"2010","unstructured":"Singh P, Carraher C, Schwarzbauer J (2010) Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26:397\u2013419","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"3675_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","volume":"120","author":"P Berraondo","year":"2019","unstructured":"Berraondo P, Sanmamed M, Ochoa M, Etxeberria I, Aznar M, P\u00e9rez-Gracia J, Rodr\u00edguez-Ruiz M, Ponz-Sarvise M, Casta\u00f1\u00f3n E, Melero I (2019) Cytokines in clinical cancer immunotherapy. Br J Cancer 120(1):6\u201315","journal-title":"Br J Cancer"},{"issue":"7","key":"3675_CR16","first-page":"1049","volume":"1832","author":"L Borthwick","year":"2013","unstructured":"Borthwick L, Wynn T, Fisher A (2013) Cytokine mediated tissue fibrosis. Biochem Biophys Acta 1832(7):1049\u20131060","journal-title":"Biochem Biophys Acta"},{"issue":"5","key":"3675_CR17","volume":"1878","author":"M Li","year":"2023","unstructured":"Li M, Wu B, Li L, Lv C, Tian Y (2023) Reprogramming of cancer-associated fibroblasts combined with immune checkpoint inhibitors: a potential therapeutic strategy for cancers. Biochim Biophys Acta 1878(5):188945","journal-title":"Biochim Biophys Acta"},{"key":"3675_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jconrel.2021.07.009","volume":"336","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liang S, Jiang D, Gao T, Fang Y, Fu S, Guan L, Zhang Z, Mu W, Chu Q et al (2021) Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies. J Control Release 336:621\u2013634","journal-title":"J Control Release"},{"issue":"3","key":"3675_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Investig 122(3):787\u2013795","journal-title":"J Clin Investig"},{"key":"3675_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A (2020) Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol 15:123\u2013147","journal-title":"Annu Rev Pathol"},{"key":"3675_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2012.12.018","volume":"152","author":"R Ostuni","year":"2013","unstructured":"Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, Curina A, Prosperini E, Ghisletti S, Natoli G (2013) Latent enhancers activated by stimulation in differentiated cells. Cell 152:157\u2013171","journal-title":"Cell"},{"issue":"7","key":"3675_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"R Ma","year":"2022","unstructured":"Ma R, Black A, Qian B (2022) Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol 43(7):546\u2013563","journal-title":"Trends Immunol"},{"key":"3675_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.668349","volume":"11","author":"G Gunaydin","year":"2021","unstructured":"Gunaydin G (2021) CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion. Front Oncol 11:668349","journal-title":"Front Oncol"},{"issue":"1","key":"3675_CR24","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1038\/s41467-023-41518-w","volume":"14","author":"S Mayer","year":"2023","unstructured":"Mayer S, Milo T, Isaacson A, Halperin C, Miyara S, Stein Y, Lior C, Pevsner-Fischer M, Tzahor E, Mayo A et al (2023) The tumor microenvironment shows a hierarchy of cell-cell interactions dominated by fibroblasts. Nat Commun 14(1):5810","journal-title":"Nat Commun"},{"issue":"9","key":"3675_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/2326-6066.CIR-16-0072","volume":"4","author":"M Ascierto","year":"2016","unstructured":"Ascierto M, McMiller T, Berger A, Danilova L, Anders R, Netto G, Xu H, Pritchard T, Fan J, Cheadle C et al (2016) The intratumoral balance between metabolic and immunologic gene expression is associated with anti-PD-1 response in patients with renal cell carcinoma. Cancer Immunol Res 4(9):726\u2013733","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"3675_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","volume":"8","author":"S Wei","year":"2018","unstructured":"Wei S, Duffy C, Allison J (2018) Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov 8(9):1069\u20131086","journal-title":"Cancer Discov"},{"issue":"1","key":"3675_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","volume":"7","author":"D Wang","year":"2022","unstructured":"Wang D, Wu X, Sun Y (2022) Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response. Signal Transduct Target Ther 7(1):331","journal-title":"Signal Transduct Target Ther"},{"key":"3675_CR28","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","volume":"11","author":"A Labani-Motlagh","year":"2020","unstructured":"Labani-Motlagh A, Ashja-Mahdavi M, Loskog A (2020) The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol 11:940","journal-title":"Front Immunol"},{"key":"3675_CR29","doi-asserted-by":"publisher","first-page":"1191660","DOI":"10.3389\/fonc.2023.1191660","volume":"13","author":"A Xu","year":"2023","unstructured":"Xu A, Xu X, Luo Z, Huang X, Gong R, Fu D (2023) Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis. Front Oncol 13:1191660","journal-title":"Front Oncol"},{"issue":"1","key":"3675_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","volume":"40","author":"W Fang","year":"2021","unstructured":"Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H, Zeng Q, Wang Y, Jin F, Chai C et al (2021) Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8 T cell exclusion. J Exp Clin Cancer Res 40(1):4","journal-title":"J Exp Clin Cancer Res"},{"key":"3675_CR31","doi-asserted-by":"publisher","first-page":"1190883","DOI":"10.3389\/fimmu.2023.1190883","volume":"14","author":"H Ai","year":"2023","unstructured":"Ai H, Yang H, Li L, Ma J, Liu K, Li Z (2023) Cancer\/testis antigens: promising immunotherapy targets for digestive tract cancers. Front Immunol 14:1190883","journal-title":"Front Immunol"},{"issue":"10","key":"3675_CR32","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558","journal-title":"Nat Med"},{"issue":"26","key":"3675_CR33","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"S Topalian","year":"2012","unstructured":"Topalian S, Hodi F, Brahmer J, Gettinger S, Smith D, McDermott D, Powderly J, Carvajal R, Sosman J, Atkins M et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366(26):2443\u20132454","journal-title":"N Engl J Med"},{"issue":"10","key":"3675_CR34","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1084\/jem.20101159","volume":"208","author":"M Fuertes","year":"2011","unstructured":"Fuertes M, Kacha A, Kline J, Woo S, Kranz D, Murphy K, Gajewski T (2011) Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med 208(10):2005\u20132016","journal-title":"J Exp Med"},{"key":"3675_CR35","doi-asserted-by":"crossref","unstructured":"Kather J, Suarez-Carmona M, Charoentong P, Weis C, Hirsch D, Bankhead P, Horning M, Ferber D, Kel I, Herpel E et al (2018) Topography of cancer-associated immune cells in human solid tumors. eLife 7:e36967","DOI":"10.7554\/eLife.36967"},{"issue":"12","key":"3675_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1240857","volume":"5","author":"E Salerno","year":"2016","unstructured":"Salerno E, Bedognetti D, Mauldin I, Deacon D, Shea S, Pinczewski J, Obeid J, Coukos G, Wang E, Gajewski T et al (2016) Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk. Oncoimmunology 5(12):e1240857","journal-title":"Oncoimmunology"},{"key":"3675_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","volume":"10","author":"A Vilgelm","year":"2019","unstructured":"Vilgelm A, Richmond A (2019) Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy. Front Immunol 10:333","journal-title":"Front Immunol"},{"issue":"7","key":"3675_CR38","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin H, Meng Y, Peterson A, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski T (2009) Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Can Res 69(7):3077\u20133085","journal-title":"Can Res"},{"issue":"3","key":"3675_CR39","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ijc.28391","volume":"134","author":"E Salerno","year":"2014","unstructured":"Salerno E, Olson W, McSkimming C, Shea S, Slingluff C (2014) T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins. Int J Cancer 134(3):563\u2013574","journal-title":"Int J Cancer"},{"issue":"5","key":"3675_CR40","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","volume":"72","author":"G Erdag","year":"2012","unstructured":"Erdag G, Schaefer J, Smolkin M, Deacon D, Shea S, Dengel L, Patterson J, Slingluff C (2012) Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Can Res 72(5):1070\u20131080","journal-title":"Can Res"},{"issue":"2","key":"3675_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3892\/or.2020.7891","volume":"45","author":"A Zeng","year":"2021","unstructured":"Zeng A, Liang X, Zhu S, Liu C, Wang S, Zhang Q, Zhao J, Song L (2021) Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF-\u03baB signaling pathway. Oncol Rep 45(2):717\u2013727","journal-title":"Oncol Rep"},{"issue":"12","key":"3675_CR42","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-14-0160","volume":"2","author":"M Chow","year":"2014","unstructured":"Chow M, Luster A (2014) Chemokines in cancer. Cancer Immunol Res 2(12):1125\u20131131","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"3675_CR43","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","volume":"9","author":"M Ruiz de Galarreta","year":"2019","unstructured":"Ruiz de Galarreta M, Bresnahan E, Molina-S\u00e1nchez P, Lindblad K, Maier B, Sia D, Puigvehi M, Miguela V, Casanova-Acebes M, Dhainaut M et al (2019) \u03b2-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma. Cancer Discov 9(8):1124\u20131141","journal-title":"Cancer Discov"},{"issue":"7559","key":"3675_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger S, Bao R, Gajewski T (2015) Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature 523(7559):231\u2013235","journal-title":"Nature"},{"issue":"11","key":"3675_CR45","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"G Dunn","year":"2002","unstructured":"Dunn G, Bruce A, Ikeda H, Old L, Schreiber R (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3(11):991\u2013998","journal-title":"Nat Immunol"},{"issue":"3","key":"3675_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1086862","volume":"5","author":"S Spranger","year":"2016","unstructured":"Spranger S, Gajewski T (2016) Tumor-intrinsic oncogene pathways mediating immune avoidance. Oncoimmunology 5(3):e1086862","journal-title":"Oncoimmunology"},{"issue":"6117","key":"3675_CR47","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1232227","volume":"339","author":"L Coussens","year":"2013","unstructured":"Coussens L, Zitvogel L, Palucka A (2013) Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339(6117):286\u2013291","journal-title":"Science"},{"issue":"4","key":"3675_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","volume":"2","author":"E Mittendorf","year":"2014","unstructured":"Mittendorf E, Philips A, Meric-Bernstam F, Qiao N, Wu Y, Harrington S, Su X, Wang Y, Gonzalez-Angulo A, Akcakanat A et al (2014) PD-L1 expression in triple-negative breast cancer. Cancer Immunol Res 2(4):361\u2013370","journal-title":"Cancer Immunol Res"},{"issue":"12","key":"3675_CR49","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1158\/0008-5472.CAN-11-4062","volume":"72","author":"S Ihara","year":"2012","unstructured":"Ihara S, Kida H, Arase H, Tripathi L, Chen Y, Kimura T, Yoshida M, Kashiwa Y, Hirata H, Fukamizu R et al (2012) Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis. Can Res 72(12):2990\u20132999","journal-title":"Can Res"},{"key":"3675_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.112938","volume":"190","author":"K Papavassiliou","year":"2023","unstructured":"Papavassiliou K, Basdra E, Papavassiliou A (2023) The emerging promise of tumour mechanobiology in cancer treatment. Eur J Cancer 190:112938","journal-title":"Eur J Cancer"},{"issue":"7015","key":"3675_CR51","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","volume":"432","author":"N Bhowmick","year":"2004","unstructured":"Bhowmick N, Neilson E, Moses H (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432(7015):332\u2013337","journal-title":"Nature"},{"issue":"1","key":"3675_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tcb.2010.08.015","volume":"21","author":"H Yu","year":"2011","unstructured":"Yu H, Mouw J, Weaver V (2011) Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol 21(1):47\u201356","journal-title":"Trends Cell Biol"},{"key":"3675_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604967","volume":"11","author":"V Pietrobon","year":"2020","unstructured":"Pietrobon V, Cesano A, Marincola F, Kather J (2020) Next generation imaging techniques to define immune topographies in solid tumors. Front Immunol 11:604967","journal-title":"Front Immunol"},{"issue":"1","key":"3675_CR54","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1038\/s41467-019-10968-6","volume":"10","author":"C Vennin","year":"2019","unstructured":"Vennin C, M\u00e9l\u00e9nec P, Rouet R, Nobis M, Cazet A, Murphy K, Herrmann D, Reed D, Lucas M, Warren S et al (2019) CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Nat Commun 10(1):3637","journal-title":"Nat Commun"},{"key":"3675_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.matbio.2018.03.016","volume":"68\u201369","author":"E Brauchle","year":"2018","unstructured":"Brauchle E, Kasper J, Daum R, Schierbaum N, Falch C, Kirschniak A, Sch\u00e4ffer T, Schenke-Layland K (2018) Biomechanical and biomolecular characterization of extracellular matrix structures in human colon carcinomas. Matrix Biol 68\u201369:180\u2013193","journal-title":"Matrix Biol"},{"issue":"5","key":"3675_CR56","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"K Levental","year":"2009","unstructured":"Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J, Fong S, Csiszar K, Giaccia A, Weninger W et al (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5):891\u2013906","journal-title":"Cell"},{"issue":"6","key":"3675_CR57","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nrc1094","volume":"3","author":"R Kalluri","year":"2003","unstructured":"Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3(6):422\u2013433","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3675_CR58","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1038\/s41467-022-30306-7","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Yong T, Wei Z, Bie N, Zhang X, Zhan G, Li J, Qin J, Yu J, Zhang B et al (2022) Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nat Commun 13(1):2794","journal-title":"Nat Commun"},{"issue":"3","key":"3675_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1158\/1541-7786.MCR-15-0307","volume":"14","author":"D Pankova","year":"2016","unstructured":"Pankova D, Chen Y, Terajima M, Schliekelman M, Baird B, Fahrenholtz M, Sun L, Gill B, Vadakkan T, Kim M et al (2016) Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma. Mol Cancer Res 14(3):287\u2013295","journal-title":"Mol Cancer Res"},{"issue":"6","key":"3675_CR60","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","volume":"39","author":"S Affo","year":"2021","unstructured":"Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X et al (2021) Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 39(6):866-882.e811","journal-title":"Cancer Cell"},{"key":"3675_CR61","doi-asserted-by":"publisher","first-page":"1194835","DOI":"10.3389\/fonc.2023.1194835","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Wang C, Huang T, Yu X, Tian B (2023) The role of cancer-associated fibroblasts in breast cancer metastasis. Front Oncol 13:1194835","journal-title":"Front Oncol"},{"issue":"21","key":"3675_CR62","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1158\/1078-0432.CCR-18-0125","volume":"24","author":"H Cho","year":"2018","unstructured":"Cho H, Seo Y, Loke K, Kim S, Oh S, Kim J, Soh J, Kim H, Lee H, Kim J et al (2018) Cancer-stimulated CAFs enhance monocyte differentiation and protumoral TAM activation via IL6 and GM-CSF secretion. Clin Cancer Res 24(21):5407\u20135421","journal-title":"Clin Cancer Res"},{"key":"3675_CR63","doi-asserted-by":"crossref","unstructured":"Rizvi S, Wang J, El-Khoueiry A (2021) Liver cancer immunity. Hepatology 73(Suppl 1):86\u2013103","DOI":"10.1002\/hep.31416"},{"issue":"4","key":"3675_CR64","first-page":"215","volume":"19","author":"H Salmon","year":"2019","unstructured":"Salmon H, Remark R, Gnjatic S, Merad M (2019) Host tissue determinants of tumour immunity. Nat Rev Cancer 19(4):215\u2013227","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3675_CR65","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","volume":"9","author":"L Arpinati","year":"2023","unstructured":"Arpinati L, Scherz-Shouval R (2023) From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts. Trends Cancer 9(5):421\u2013443","journal-title":"Trends Cancer"},{"issue":"7637","key":"3675_CR66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"D Chen","year":"2017","unstructured":"Chen D, Mellman I (2017) Elements of cancer immunity and the cancer-immune set point. Nature 541(7637):321\u2013330","journal-title":"Nature"},{"issue":"1","key":"3675_CR67","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41467-020-14425-7","volume":"11","author":"Y Huang","year":"2020","unstructured":"Huang Y, Chen Y, Zhou S, Chen L, Wang J, Pei Y, Xu M, Feng J, Jiang T, Liang K et al (2020) Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors. Nat Commun 11(1):622","journal-title":"Nat Commun"},{"issue":"9","key":"3675_CR68","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582\u2013598","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3675_CR69","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jaci.2017.12.998","volume":"142","author":"H Cheng","year":"2018","unstructured":"Cheng H, Onder L, Cupovic J, Boesch M, Novkovic M, Pikor N, Tarantino I, Rodriguez R, Schneider T, Jochum W et al (2018) CCL19-producing fibroblastic stromal cells restrain lung carcinoma growth by promoting local antitumor T-cell responses. J Allergy Clin Immunol 142(4):1257-1271.e1254","journal-title":"J Allergy Clin Immunol"},{"issue":"5795","key":"3675_CR70","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, Tosolini M, Camus M, Berger A, Wind P et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960\u20131964","journal-title":"Science"},{"key":"3675_CR71","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fcell.2019.00060","volume":"7","author":"T Liu","year":"2019","unstructured":"Liu T, Zhou L, Li D, Andl T, Zhang Y (2019) Cancer-associated fibroblasts build and secure the tumor microenvironment. Front Cell Dev Biol 7:60","journal-title":"Front Cell Dev Biol"},{"key":"3675_CR72","doi-asserted-by":"crossref","unstructured":"Clifton G, Rothenberg M, Ascierto P, Begley G, Cecchini M, Eder J, Ghiringhelli F, Italiano A, Kochetkova M, Li R et al (2023) Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop. J Immunother Cancer 11(6):e006773","DOI":"10.1136\/jitc-2023-006773"},{"issue":"11","key":"3675_CR73","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1111\/cas.15955","volume":"114","author":"Y Mezawa","year":"2023","unstructured":"Mezawa Y, Wang T, Daigo Y, Takano A, Miyagi Y, Yokose T, Yamashita T, Yang L, Maruyama R, Seimiya H et al (2023) Glutamine deficiency drives transforming growth factor-\u03b2 signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts. Cancer Sci 114(11):4376\u20134387","journal-title":"Cancer Sci"},{"issue":"1","key":"3675_CR74","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/imr.12982","volume":"302","author":"M Desbois","year":"2021","unstructured":"Desbois M, Wang Y (2021) Cancer-associated fibroblasts: key players in shaping the tumor immune microenvironment. Immunol Rev 302(1):241\u2013258","journal-title":"Immunol Rev"},{"issue":"14","key":"3675_CR75","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1158\/1078-0432.CCR-07-5211","volume":"14","author":"E Ostermann","year":"2008","unstructured":"Ostermann E, Garin-Chesa P, Heider K, Kalat M, Lamche H, Puri C, Kerjaschki D, Rettig W, Adolf G (2008) Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts. Clin Cancer Res 14(14):4584\u20134592","journal-title":"Clin Cancer Res"},{"issue":"40","key":"3675_CR76","doi-asserted-by":"publisher","first-page":"11208","DOI":"10.1073\/pnas.1610347113","volume":"113","author":"W Han","year":"2016","unstructured":"Han W, Chen S, Yuan W, Fan Q, Tian J, Wang X, Chen L, Zhang X, Wei W, Liu R et al (2016) Oriented collagen fibers direct tumor cell intravasation. Proc Natl Acad Sci USA 113(40):11208\u201311213","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3675_CR77","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1073\/pnas.1818357116","volume":"116","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Cao J, Melamed A, Worley M, Gockley A, Jones D, Nia H, Zhang Y, Stylianopoulos T, Kumar A et al (2019) Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma. Proc Natl Acad Sci USA 116(6):2210\u20132219","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"3675_CR78","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","volume":"5","author":"J Murphy","year":"2019","unstructured":"Murphy J, Wo J, Ryan D, Clark J, Jiang W, Yeap B, Drapek L, Ly L, Baglini C, Blaszkowsky L et al (2019) Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial. JAMA Oncol 5(7):1020\u20131027","journal-title":"JAMA Oncol"},{"issue":"3","key":"3675_CR79","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/path.2278","volume":"214","author":"A Bergamaschi","year":"2008","unstructured":"Bergamaschi A, Tagliabue E, S\u00f8rlie T, Naume B, Triulzi T, Orlandi R, Russnes H, Nesland J, Tammi R, Auvinen P et al (2008) Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol 214(3):357\u2013367","journal-title":"J Pathol"},{"issue":"2","key":"3675_CR80","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jlb.67.2.149","volume":"67","author":"G Vaday","year":"2000","unstructured":"Vaday G, Lider O (2000) Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 67(2):149\u2013159","journal-title":"J Leukoc Biol"},{"issue":"5","key":"3675_CR81","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1021\/acsnano.0c00417","volume":"14","author":"A Nicol\u00e1s-Boluda","year":"2020","unstructured":"Nicol\u00e1s-Boluda A, Vaquero J, Laurent G, Renault G, Bazzi R, Donnadieu E, Roux S, Fouassier L, Gazeau F (2020) Photothermal depletion of cancer-associated fibroblasts normalizes tumor stiffness in desmoplastic cholangiocarcinoma. ACS Nano 14(5):5738\u20135753","journal-title":"ACS Nano"},{"issue":"9","key":"3675_CR82","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1021\/acsbiomaterials.3c00487","volume":"9","author":"T Gong","year":"2023","unstructured":"Gong T, Wu D, Pan H, Sun Z, Yao X, Wang D, Huang Y, Li X, Guo Y, Lu Y (2023) Biomimetic microenvironmental stiffness boosts stemness of pancreatic ductal adenocarcinoma via augmented autophagy. ACS Biomater Sci Eng 9(9):5347\u20135360","journal-title":"ACS Biomater Sci Eng"},{"issue":"10","key":"3675_CR83","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1039\/c5ib00040h","volume":"7","author":"I Acerbi","year":"2015","unstructured":"Acerbi I, Cassereau L, Dean I, Shi Q, Au A, Park C, Chen Y, Liphardt J, Hwang E, Weaver V (2015) Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol 7(10):1120\u20131134","journal-title":"Integr Biol"},{"issue":"1","key":"3675_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-019-0500-6","volume":"26","author":"A Kogure","year":"2019","unstructured":"Kogure A, Kosaka N, Ochiya T (2019) Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis. J Biomed Sci 26(1):7","journal-title":"J Biomed Sci"},{"issue":"1","key":"3675_CR85","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Liu L, Liu J, Dang P, Hu S, Yuan W, Sun Z, Liu Y, Wang C (2023) Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers. Mol Cancer 22(1):58","journal-title":"Mol Cancer"},{"issue":"6","key":"3675_CR86","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"M Pittet","year":"2022","unstructured":"Pittet M, Michielin O, Migliorini D (2022) Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol 19(6):402\u2013421","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"3675_CR87","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00262-013-1487-6","volume":"62","author":"M Santoni","year":"2013","unstructured":"Santoni M, Massari F, Amantini C, Nabissi M, Maines F, Burattini L, Berardi R, Santoni G, Montironi R, Tortora G et al (2013) Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 62(12):1757\u20131768","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"3675_CR88","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/0008-5472.CAN-14-0992","volume":"75","author":"J Escamilla","year":"2015","unstructured":"Escamilla J, Schokrpur S, Liu C, Priceman S, Moughon D, Jiang Z, Pouliot F, Magyar C, Sung J, Xu J et al (2015) CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Can Res 75(6):950\u2013962","journal-title":"Can Res"},{"issue":"4","key":"3675_CR89","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens L (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27(4):462\u2013472","journal-title":"Cancer Cell"},{"issue":"12","key":"3675_CR90","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26968","volume":"2","author":"D Strachan","year":"2013","unstructured":"Strachan D, Ruffell B, Oei Y, Bissell M, Coussens L, Pryer N, Daniel D (2013) CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells. Oncoimmunology 2(12):e26968","journal-title":"Oncoimmunology"},{"issue":"4","key":"3675_CR91","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/febs.14343","volume":"285","author":"P Jeannin","year":"2018","unstructured":"Jeannin P, Paolini L, Adam C, Delneste Y (2018) The roles of CSFs on the functional polarization of tumor-associated macrophages. FEBS J 285(4):680\u2013699","journal-title":"FEBS J"},{"issue":"1","key":"3675_CR92","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12967-020-02618-z","volume":"18","author":"I Hwang","year":"2020","unstructured":"Hwang I, Kim J, Ylaya K, Chung E, Kitano H, Perry C, Hanaoka J, Fukuoka J, Chung J, Hewitt S (2020) Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients. J Transl Med 18(1):443","journal-title":"J Transl Med"},{"key":"3675_CR93","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"C Ngambenjawong","year":"2017","unstructured":"Ngambenjawong C, Gustafson H, Pun S (2017) Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 114:206\u2013221","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3675_CR94","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12957-018-1312-y","volume":"16","author":"R Yao","year":"2018","unstructured":"Yao R, Li J, Zhang R, Chen R, Wang Y (2018) M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4\/STAT3 signaling pathway. World J Surg Oncol 16(1):9","journal-title":"World J Surg Oncol"},{"issue":"5","key":"3675_CR95","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1158\/2326-6066.CIR-14-0232","volume":"3","author":"S Shiao","year":"2015","unstructured":"Shiao S, Ruffell B, DeNardo D, Faddegon B, Park C, Coussens L (2015) TH2-polarized CD4(+) T cells and macrophages limit efficacy of radiotherapy. Cancer Immunol Res 3(5):518\u2013525","journal-title":"Cancer Immunol Res"},{"key":"3675_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.12.011","volume":"130","author":"D Mangani","year":"2017","unstructured":"Mangani D, Weller M, Roth P (2017) The network of immunosuppressive pathways in glioblastoma. Biochem Pharmacol 130:1\u20139","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"3675_CR97","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002181","volume":"9","author":"E Simonds","year":"2021","unstructured":"Simonds E, Lu E, Badillo O, Karimi S, Liu E, Tamaki W, Rancan C, Downey K, Stultz J, Sinha M et al (2021) Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. J Immunother Cancer 9(6):e002181","journal-title":"J Immunother Cancer"},{"issue":"7655","key":"3675_CR98","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"S Gordon","year":"2017","unstructured":"Gordon S, Maute R, Dulken B, Hutter G, George B, McCracken M, Gupta R, Tsai J, Sinha R, Corey D et al (2017) PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545(7655):495\u2013499","journal-title":"Nature"},{"issue":"6","key":"3675_CR99","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1039\/C9BM00155G","volume":"7","author":"H Kim","year":"2019","unstructured":"Kim H, Cha J, Jang M, Kim P (2019) Hyaluronic acid-based extracellular matrix triggers spontaneous M2-like polarity of monocyte\/macrophage. Biomaterials Science 7(6):2264\u20132271","journal-title":"Biomaterials Science"},{"issue":"1","key":"3675_CR100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/path.2370","volume":"216","author":"Y Komohara","year":"2008","unstructured":"Komohara Y, Ohnishi K, Kuratsu J, Takeya M (2008) Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216(1):15\u201324","journal-title":"J Pathol"},{"issue":"1","key":"3675_CR101","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40425-018-0376-0","volume":"6","author":"M Mushtaq","year":"2018","unstructured":"Mushtaq M, Papadas A, Pagenkopf A, Flietner E, Morrow Z, Chaudhary S, Asimakopoulos F (2018) Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers. J Immunother Cancer 6(1):65","journal-title":"J Immunother Cancer"},{"issue":"3","key":"3675_CR102","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher T (2018) Regulation and function of the PD-L1 checkpoint. Immunity 48(3):434\u2013452","journal-title":"Immunity"},{"issue":"2","key":"3675_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.33","volume":"7","author":"W Chen","year":"2016","unstructured":"Chen W, Wang J, Jia L, Liu J, Tian Y (2016) Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan. Cell Death Dis 7(2):e2115","journal-title":"Cell Death Dis"},{"issue":"6","key":"3675_CR104","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1158\/1541-7786.MCR-21-0786","volume":"20","author":"A Tsuruta","year":"2022","unstructured":"Tsuruta A, Shiiba Y, Matsunaga N, Fujimoto M, Yoshida Y, Koyanagi S, Ohdo S (2022) Diurnal expression of PD-1 on tumor-associated macrophages underlies the dosing time-dependent antitumor effects of the PD-1\/PD-L1 inhibitor BMS-1 in B16\/BL6 melanoma-bearing mice. Mol Cancer Res 20(6):972\u2013982","journal-title":"Mol Cancer Res"},{"issue":"4","key":"3675_CR105","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1158\/1078-0432.CCR-19-1040","volume":"26","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zugazagoitia J, Ahmed F, Henick B, Gettinger S, Herbst R, Schalper K, Rimm D (2020) Immune cell PD-L1 colocalizes with macrophages and is associated with outcome in PD-1 pathway blockade therapy. Clin Cancer Res 26(4):970\u2013977","journal-title":"Clin Cancer Res"},{"key":"3675_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.588552","volume":"11","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Zhang H, Chen B, Liu X, Zhang S, Zong Z, Gao M (2020) PD-L1-mediated immunosuppression in glioblastoma is associated with the infiltration and M2-polarization of tumor-associated macrophages. Front Immunol 11:588552","journal-title":"Front Immunol"},{"issue":"6","key":"3675_CR107","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","volume":"170","author":"S Wei","year":"2017","unstructured":"Wei S, Levine J, Cogdill A, Zhao Y, Anang N, Andrews M, Sharma P, Wang J, Wargo J, Pe\u2019er D et al (2017) Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell 170(6):1120-1133.e1117","journal-title":"Cell"},{"issue":"3","key":"3675_CR108","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/2159-8290.CD-20-0856","volume":"11","author":"S Wei","year":"2021","unstructured":"Wei S, Meijers W, Axelrod M, Anang N, Screever E, Wescott E, Johnson D, Whitley E, Lehmann L, Courand P et al (2021) A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention. Cancer Discov 11(3):614\u2013625","journal-title":"Cancer Discov"},{"issue":"2","key":"3675_CR109","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.21.02229","volume":"40","author":"J Wolchok","year":"2022","unstructured":"Wolchok J, Chiarion-Sileni V, Gonzalez R, Grob J, Rutkowski P, Lao C, Cowey C, Schadendorf D, Wagstaff J, Dummer R et al (2022) Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma. J Clin Oncol 40(2):127\u2013137","journal-title":"J Clin Oncol"},{"issue":"1","key":"3675_CR110","doi-asserted-by":"publisher","first-page":"2026019","DOI":"10.1080\/2162402X.2022.2026019","volume":"11","author":"A Kim","year":"2022","unstructured":"Kim A, Choi S, Park J, Kwon M, Chowdhury T, Yu H, Kim S, Kang H, Kim K, Park S et al (2022) Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma. Oncoimmunology 11(1):2026019","journal-title":"Oncoimmunology"},{"issue":"6","key":"3675_CR111","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1158\/1541-7786.MCR-16-0338","volume":"15","author":"J Ju","year":"2017","unstructured":"Ju J, Godet I, Ye I, Byun J, Jayatilaka H, Lee S, Xiang L, Samanta D, Lee M, Wu P et al (2017) Hypoxia selectively enhances integrin \u03b1\u03b2 receptor expression in breast cancer to promote metastasis. Mol Cancer Res 15(6):723\u2013734","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3675_CR112","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ydbio.2009.10.026","volume":"341","author":"T Rozario","year":"2010","unstructured":"Rozario T, DeSimone D (2010) The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol 341(1):126\u2013140","journal-title":"Dev Biol"},{"key":"3675_CR113","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.10.013","volume":"97","author":"H Multhaupt","year":"2016","unstructured":"Multhaupt H, Leitinger B, Gullberg D, Couchman J (2016) Extracellular matrix component signaling in cancer. Adv Drug Deliv Rev 97:28\u201340","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"3675_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2015.35","volume":"4","author":"F Spinelli","year":"2015","unstructured":"Spinelli F, Vitale D, Demarchi G, Cristina C, Alaniz L (2015) The immunological effect of hyaluronan in tumor angiogenesis. Clin Transl Immunol 4(12):e52","journal-title":"Clin Transl Immunol"},{"issue":"2","key":"3675_CR115","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1124\/pr.109.001289","volume":"61","author":"H J\u00e4rvel\u00e4inen","year":"2009","unstructured":"J\u00e4rvel\u00e4inen H, Sainio A, Koulu M, Wight T, Penttinen R (2009) Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61(2):198\u2013223","journal-title":"Pharmacol Rev"},{"issue":"1","key":"3675_CR116","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","volume":"62","author":"M Jacobetz","year":"2013","unstructured":"Jacobetz M, Chan D, Neesse A, Bapiro T, Cook N, Frese K, Feig C, Nakagawa T, Caldwell M, Zecchini H et al (2013) Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 62(1):112\u2013120","journal-title":"Gut"},{"issue":"4","key":"3675_CR117","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tranon.2017.04.009","volume":"10","author":"L Bolm","year":"2017","unstructured":"Bolm L, Cigolla S, Wittel U, Hopt U, Keck T, Rades D, Bronsert P, Wellner U (2017) The role of fibroblasts in pancreatic cancer: extracellular matrix versus paracrine factors. Translational Oncology 10(4):578\u2013588","journal-title":"Translational Oncology"},{"key":"3675_CR118","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.actbio.2022.11.038","volume":"158","author":"G van Tienderen","year":"2023","unstructured":"van Tienderen G, Rosmark O, Lieshout R, Willemse J, de Weijer F, Elowsson Rendin L, Westergren-Thorsson G, Doukas M, Groot Koerkamp B, van Royen M et al (2023) Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition. Acta Biomater 158:115\u2013131","journal-title":"Acta Biomater"},{"issue":"6","key":"3675_CR119","first-page":"3395","volume":"42","author":"Z Liu","year":"2018","unstructured":"Liu Z, Kuang W, Zhou Q, Zhang Y (2018) TGF-\u03b21 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2\/3 signalling pathway. Int J Mol Med 42(6):3395\u20133403","journal-title":"Int J Mol Med"},{"issue":"9","key":"3675_CR120","doi-asserted-by":"publisher","first-page":"R191","DOI":"10.1186\/gb-2007-8-9-r191","volume":"8","author":"M Buess","year":"2007","unstructured":"Buess M, Nuyten D, Hastie T, Nielsen T, Pesich R, Brown P (2007) Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer. Genome Biol 8(9):R191","journal-title":"Genome Biol"},{"issue":"2","key":"3675_CR121","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/dmm.004077","volume":"4","author":"T Cox","year":"2011","unstructured":"Cox T, Erler J (2011) Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 4(2):165\u2013178","journal-title":"Dis Model Mech"},{"issue":"1","key":"3675_CR122","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson D (2021) Diversity and biology of cancer-associated fibroblasts. Physiol Rev 101(1):147\u2013176","journal-title":"Physiol Rev"},{"key":"3675_CR123","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fimmu.2014.00554","volume":"5","author":"T Hamilton","year":"2014","unstructured":"Hamilton T, Zhao C, Pavicic P, Datta S (2014) Myeloid colony-stimulating factors as regulators of macrophage polarization. Front Immunol 5:554","journal-title":"Front Immunol"},{"issue":"12","key":"3675_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004172","volume":"33","author":"J Li","year":"2021","unstructured":"Li J, Jiang X, Li H, Gelinsky M, Gu Z (2021) Tailoring materials for modulation of macrophage fate. Adv Mater 33(12):e2004172","journal-title":"Adv Mater"},{"issue":"3","key":"3675_CR125","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1101\/gad.1874010","volume":"24","author":"V Gocheva","year":"2010","unstructured":"Gocheva V, Wang H, Gadea B, Shree T, Hunter K, Garfall A, Berman T, Joyce J (2010) IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 24(3):241\u2013255","journal-title":"Genes Dev"},{"issue":"3","key":"3675_CR126","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","volume":"23","author":"M De Palma","year":"2013","unstructured":"De Palma M, Lewis C (2013) Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23(3):277\u2013286","journal-title":"Cancer Cell"},{"issue":"4","key":"3675_CR127","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccr.2011.02.005","volume":"19","author":"R Mazzieri","year":"2011","unstructured":"Mazzieri R, Pucci F, Moi D, Zonari E, Ranghetti A, Berti A, Politi L, Gentner B, Brown J, Naldini L et al (2011) Targeting the ANG2\/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19(4):512\u2013526","journal-title":"Cancer Cell"},{"issue":"2","key":"3675_CR128","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.celrep.2011.12.005","volume":"1","author":"M Squadrito","year":"2012","unstructured":"Squadrito M, Pucci F, Magri L, Moi D, Gilfillan G, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L et al (2012) miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep 1(2):141\u2013154","journal-title":"Cell Rep"},{"issue":"1","key":"3675_CR129","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-012-1056-7","volume":"125","author":"C Prada","year":"2013","unstructured":"Prada C, Jousma E, Rizvi T, Wu J, Dunn R, Mayes D, Cancelas J, Dombi E, Kim M, West B et al (2013) Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition. Acta Neuropathol 125(1):159\u2013168","journal-title":"Acta Neuropathol"},{"issue":"18","key":"3675_CR130","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1158\/1078-0432.CCR-10-0733","volume":"16","author":"K Kodumudi","year":"2010","unstructured":"Kodumudi K, Woan K, Gilvary D, Sahakian E, Wei S, Djeu J (2010) A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin Cancer Res 16(18):4583\u20134594","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3675_CR131","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/path.5224","volume":"248","author":"C Neuzillet","year":"2019","unstructured":"Neuzillet C, Tijeras-Raballand A, Ragulan C, Cros J, Patil Y, Martinet M, Erkan M, Kleeff J, Wilson J, Apte M et al (2019) Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. J Pathol 248(1):51\u201365","journal-title":"J Pathol"},{"issue":"3","key":"3675_CR132","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C et al (2018) Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33(3):463-479.e410","journal-title":"Cancer Cell"},{"issue":"1","key":"3675_CR133","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41467-018-03348-z","volume":"9","author":"A Givel","year":"2018","unstructured":"Givel A, Kieffer Y, Scholer-Dahirel A, Sirven P, Cardon M, Pelon F, Magagna I, Gentric G, Costa A, Bonneau C et al (2018) miR200-regulated CXCL12\u03b2 promotes fibroblast heterogeneity and immunosuppression in ovarian cancers. Nat Commun 9(1):1056","journal-title":"Nat Commun"},{"issue":"11","key":"3675_CR134","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/s41388-017-0036-8","volume":"37","author":"A Martinez-Ordo\u00f1ez","year":"2018","unstructured":"Martinez-Ordo\u00f1ez A, Seoane S, Cabezas P, Eiro N, Sendon-Lago J, Macia M, Garcia-Caballero T, Gonzalez L, Sanchez L, Vizoso F et al (2018) Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis. Oncogene 37(11):1430\u20131444","journal-title":"Oncogene"},{"issue":"4","key":"3675_CR135","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/path.5926","volume":"257","author":"S Menezes","year":"2022","unstructured":"Menezes S, Okail M, Jalil S, Kocher H, Cameron A (2022) Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets. J Pathol 257(4):526\u2013544","journal-title":"J Pathol"},{"issue":"2","key":"3675_CR136","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1158\/0008-5472.CAN-12-2130","volume":"73","author":"J Mertens","year":"2013","unstructured":"Mertens J, Fingas C, Christensen J, Smoot R, Bronk S, Werneburg N, Gustafson M, Dietz A, Roberts L, Sirica A et al (2013) Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Can Res 73(2):897\u2013907","journal-title":"Can Res"},{"issue":"4","key":"3675_CR137","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"F Yu","year":"2015","unstructured":"Yu F, Zhao B, Guan K (2015) Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163(4):811\u2013828","journal-title":"Cell"},{"key":"3675_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.673599","volume":"9","author":"X Cai","year":"2021","unstructured":"Cai X, Wang K, Meng Z (2021) Mechanoregulation of YAP and TAZ in cellular homeostasis and disease progression. Front Cell Dev Biol 9:673599","journal-title":"Front Cell Dev Biol"},{"issue":"7350","key":"3675_CR139","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S et al (2011) Role of YAP\/TAZ in mechanotransduction. Nature 474(7350):179\u2013183","journal-title":"Nature"},{"issue":"4","key":"3675_CR140","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.devcel.2018.04.014","volume":"45","author":"Q Li","year":"2018","unstructured":"Li Q, Nirala N, Nie Y, Chen H, Ostroff G, Mao J, Wang Q, Xu L, Ip Y (2018) Ingestion of food particles regulates the mechanosensing Misshapen-Yorkie pathway in drosophila intestinal growth. Dev Cell 45(4):433-449.e436","journal-title":"Dev Cell"},{"issue":"1","key":"3675_CR141","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13045-017-0421-3","volume":"10","author":"Y Huang","year":"2017","unstructured":"Huang Y, Yang C, Wei P, Huynh T, Whang-Peng J, Meng T, Hsiao M, Tzeng Y, Wu A, Yen Y (2017) Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways. J Hematol Oncol 10(1):60","journal-title":"J Hematol Oncol"},{"issue":"12","key":"3675_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000941","volume":"18","author":"M Mia","year":"2020","unstructured":"Mia M, Cibi D, Abdul Ghani S, Song W, Tee N, Ghosh S, Mao J, Olson E, Singh M (2020) YAP\/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. PLoS Biol 18(12):e3000941","journal-title":"PLoS Biol"},{"issue":"1","key":"3675_CR143","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1038\/s41467-022-33800-0","volume":"13","author":"H Shen","year":"2022","unstructured":"Shen H, Huang X, Zhao Y, Wu D, Xue K, Yao J, Wang Y, Tang N, Qiu Y (2022) The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis. Nat Commun 13(1):6030","journal-title":"Nat Commun"},{"issue":"11","key":"3675_CR144","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1158\/2159-8290.CD-20-0036","volume":"10","author":"I Marigo","year":"2020","unstructured":"Marigo I, Trovato R, Hofer F, Ingangi V, Desantis G, Leone K, De Sanctis F, Ugel S, Can\u00e8 S, Simonelli A et al (2020) Disabled homolog 2 controls prometastatic activity of tumor-associated macrophages. Cancer Discov 10(11):1758\u20131773","journal-title":"Cancer Discov"},{"issue":"4","key":"3675_CR145","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S1470-2045(20)30011-5","volume":"21","author":"S Qin","year":"2020","unstructured":"Qin S, Ren Z, Meng Z, Chen Z, Chai X, Xiong J, Bai Y, Yang L, Zhu H, Fang W et al (2020) Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial. Lancet Oncol 21(4):571\u2013580","journal-title":"Lancet Oncol"},{"issue":"1","key":"3675_CR146","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y (2022) Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther 7(1):196","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"3675_CR147","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.7150\/thno.58390","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sun Z (2021) Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics 11(11):5365\u20135386","journal-title":"Theranostics"},{"issue":"2","key":"3675_CR148","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.coi.2013.02.009","volume":"25","author":"T Gajewski","year":"2013","unstructured":"Gajewski T, Woo S, Zha Y, Spaapen R, Zheng Y, Corrales L, Spranger S (2013) Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment. Curr Opin Immunol 25(2):268\u2013276","journal-title":"Curr Opin Immunol"},{"issue":"6230","key":"3675_CR149","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"J Joyce","year":"2015","unstructured":"Joyce J, Fearon D (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348(6230):74\u201380","journal-title":"Science"},{"issue":"11","key":"3675_CR150","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1158\/2326-6066.CIR-17-0375","volume":"5","author":"D Le","year":"2017","unstructured":"Le D, Hubbard-Lucey V, Morse M, Heery C, Dwyer A, Marsilje T, Brodsky A, Chan E, Deming D, Diaz L et al (2017) A blueprint to advance colorectal cancer immunotherapies. Cancer Immunol Res 5(11):942\u2013949","journal-title":"Cancer Immunol Res"},{"issue":"10135","key":"3675_CR151","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s F, Mlecnik B, Marliot F, Bindea G, Ou F, Bifulco C, Lugli A, Zlobec I, Rau T, Berger M et al (2018) International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391(10135):2128\u20132139","journal-title":"Lancet"},{"issue":"3","key":"3675_CR152","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI45817","volume":"122","author":"H Salmon","year":"2012","unstructured":"Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean M, Validire P, Trautmann A, Mami-Chouaib F, Donnadieu E (2012) Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Investig 122(3):899\u2013910","journal-title":"J Clin Investig"},{"key":"3675_CR153","doi-asserted-by":"crossref","unstructured":"Nicolas-Boluda A, Vaquero J, Vimeux L, Guilbert T, Barrin S, Kantari-Mimoun C, Ponzo M, Renault G, Deptula P, Pogoda K et al (2021) Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. eLife 10:e58688.","DOI":"10.7554\/eLife.58688"},{"key":"3675_CR154","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1039\/D3LC00660C","volume":"24","author":"D Kpeglo","year":"2024","unstructured":"Kpeglo D, Haddrick M, Knowles M, Evans S, Peyman S (2024) Modelling and breaking down the biophysical barriers to drug delivery in pancreatic cancer. Lab Chip 24:854\u2013868","journal-title":"Lab Chip"},{"issue":"9","key":"3675_CR155","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc2714","volume":"9","author":"M Meads","year":"2009","unstructured":"Meads M, Gatenby R, Dalton W (2009) Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer 9(9):665\u2013674","journal-title":"Nat Rev Cancer"},{"key":"3675_CR156","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jconrel.2017.06.022","volume":"261","author":"F Mpekris","year":"2017","unstructured":"Mpekris F, Papageorgis P, Polydorou C, Voutouri C, Kalli M, Pirentis A, Stylianopoulos T (2017) Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy. J Control Release 261:105\u2013112","journal-title":"J Control Release"},{"issue":"1","key":"3675_CR157","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1038\/s41467-022-34744-1","volume":"13","author":"M Panagi","year":"2022","unstructured":"Panagi M, Mpekris F, Chen P, Voutouri C, Nakagawa Y, Martin J, Hiroi T, Hashimoto H, Demetriou P, Pierides C et al (2022) Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models. Nat Commun 13(1):7165","journal-title":"Nat Commun"},{"issue":"4","key":"3675_CR158","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.7150\/thno.36936","volume":"10","author":"M Panagi","year":"2020","unstructured":"Panagi M, Voutouri C, Mpekris F, Papageorgis P, Martin M, Martin J, Demetriou P, Pierides C, Polydorou C, Stylianou A et al (2020) TGF-\u03b2 inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity. Theranostics 10(4):1910\u20131922","journal-title":"Theranostics"},{"issue":"15","key":"3675_CR159","doi-asserted-by":"publisher","first-page":"24506","DOI":"10.18632\/oncotarget.15534","volume":"8","author":"C Polydorou","year":"2017","unstructured":"Polydorou C, Mpekris F, Papageorgis P, Voutouri C, Stylianopoulos T (2017) Pirfenidone normalizes the tumor microenvironment to improve chemotherapy. Oncotarget 8(15):24506\u201324517","journal-title":"Oncotarget"},{"issue":"6","key":"3675_CR160","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1021\/acsnano.8b07865","volume":"13","author":"J Martin","year":"2019","unstructured":"Martin J, Panagi M, Wang C, Khan T, Martin M, Voutouri C, Toh K, Papageorgis P, Mpekris F, Polydorou C et al (2019) Dexamethasone increases cisplatin-loaded nanocarrier delivery and efficacy in metastatic breast cancer by normalizing the tumor microenvironment. ACS Nano 13(6):6396\u20136408","journal-title":"ACS Nano"},{"key":"3675_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L (2022) Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol 13:888713","journal-title":"Front Immunol"},{"issue":"1","key":"3675_CR162","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z (2019) Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci 26(1):78","journal-title":"J Biomed Sci"},{"issue":"1","key":"3675_CR163","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.1038\/s41598-021-85491-0","volume":"11","author":"M Rodr\u00edguez","year":"2021","unstructured":"Rodr\u00edguez M, Onorato A, Cantero M, Dom\u00ednguez L, Bayo J, Fiore E, Garc\u00eda M, Atorrasagasti C, Canbay A, Malvicini M et al (2021) 4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice. Sci Rep 11(1):6310","journal-title":"Sci Rep"},{"issue":"10","key":"3675_CR164","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2217\/imt.13.102","volume":"5","author":"R Panni","year":"2013","unstructured":"Panni R, Linehan D, DeNardo D (2013) Targeting tumor-infiltrating macrophages to combat cancer. Immunotherapy 5(10):1075\u20131087","journal-title":"Immunotherapy"},{"issue":"2","key":"3675_CR165","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/stem.1281","volume":"31","author":"J Yang","year":"2013","unstructured":"Yang J, Liao D, Chen C, Liu Y, Chuang T, Xiang R, Markowitz D, Reisfeld R, Luo Y (2013) Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR\/Stat3\/Sox-2 signaling pathway. Stem Cells 31(2):248\u2013258","journal-title":"Stem Cells"},{"issue":"3","key":"3675_CR166","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","volume":"73","author":"J Mitchem","year":"2013","unstructured":"Mitchem J, Brennan D, Knolhoff B, Belt B, Zhu Y, Sanford D, Belaygorod L, Carpenter D, Collins L, Piwnica-Worms D et al (2013) Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Can Res 73(3):1128\u20131141","journal-title":"Can Res"},{"issue":"1","key":"3675_CR167","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13045-020-00983-2","volume":"13","author":"L Zhang","year":"2020","unstructured":"Zhang L, Tian L, Dai X, Yu H, Wang J, Lei A, Zhu M, Xu J, Zhao W, Zhu Y et al (2020) Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions. J Hematol Oncol 13(1):153","journal-title":"J Hematol Oncol"},{"issue":"8","key":"3675_CR168","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky M, Ruella M, Shestova O, Lu X, Best A, Zeeman M, Schmierer M, Gabrusiewicz K, Anderson N, Petty N et al (2020) Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol 38(8):947\u2013953","journal-title":"Nat Biotechnol"},{"issue":"10","key":"3675_CR169","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.3390\/jcm9103226","volume":"9","author":"C Belgiovine","year":"2020","unstructured":"Belgiovine C, Digifico E, Anfray C, Ummarino A, Torres And\u00f3n F (2020) Targeting tumor-associated macrophages in anti-cancer therapies: convincing the traitors to do the right thing. J Clin Med 9(10):3226","journal-title":"J Clin Med"},{"issue":"12","key":"3675_CR170","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1659096","volume":"8","author":"K Kapp","year":"2019","unstructured":"Kapp K, Volz B, Oswald D, Wittig B, Baumann M, Schmidt M (2019) Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors. Oncoimmunology 8(12):e1659096","journal-title":"Oncoimmunology"},{"issue":"18","key":"3675_CR171","doi-asserted-by":"publisher","DOI":"10.1172\/JCI159181","volume":"133","author":"R Devarajan","year":"2023","unstructured":"Devarajan R, Izzi V, Peltoketo H, Rask G, Kauppila S, V\u00e4is\u00e4nen M, Ruotsalainen H, Mart\u00ednez-Nieto G, Karppinen S, V\u00e4is\u00e4nen T et al (2023) Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models. J Clin Investig 133(18):e159181","journal-title":"J Clin Investig"},{"issue":"24","key":"3675_CR172","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1158\/0008-5472.CAN-21-3603","volume":"81","author":"W Ho","year":"2021","unstructured":"Ho W, Jaffee E (2021) Macrophage-targeting by CSF1\/1R blockade in pancreatic cancers. Can Res 81(24):6071\u20136073","journal-title":"Can Res"},{"issue":"1","key":"3675_CR173","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41467-022-29388-0","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, Ding Y, Liu J, Wang J, Mo F, Wang Y, Chen-Mayfield T, Sondel P, Hong S, Hu Q (2022) Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment. Nat Commun 13(1):1845","journal-title":"Nat Commun"},{"issue":"1","key":"3675_CR174","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-021-01954-2","volume":"40","author":"Q Chen","year":"2021","unstructured":"Chen Q, Jin J, Huang X, Wu F, Huang H, Zhan R (2021) EMP3 mediates glioblastoma-associated macrophage infiltration to drive T cell exclusion. J Exp Clin Cancer Res 40(1):160","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-024-03675-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-024-03675-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-024-03675-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T13:03:46Z","timestamp":1715432626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-024-03675-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":174,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["3675"],"URL":"https:\/\/doi.org\/10.1007\/s00262-024-03675-9","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"12 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"115"}}